{"result": "(\"entity\"<|>CATABOLISMO<|>EVENT<|>Catabolism refers to the metabolic process that breaks down molecules to obtain energy, which is relevant in the context of nutrition and health.)\n##\n(\"entity\"<|>AMINOÁCIDOS<|>ORGANIZATION<|>Amino acids are organic compounds that combine to form proteins and are crucial in nutrition, especially in the context of parenteral nutrition.)\n##\n(\"entity\"<|>FIEBRE<|>EVENT<|>Fever is a common symptom that may indicate infection and is relevant in the context of managing patients on parenteral nutrition.)\n##\n(\"entity\"<|>SEPSIS<|>EVENT<|>Sepsis is a life-threatening condition caused by the body's response to infection, significant in the context of complications in parenteral nutrition.)\n##\n(\"entity\"<|>TROMBOSIS<|>EVENT<|>Thrombosis refers to the formation of a blood clot inside a blood vessel, which is a risk associated with the use of catheters in parenteral nutrition.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL<|>EVENT<|>Parenteral nutrition is a medical method of feeding a person intravenously, bypassing the usual process of eating and digestion.)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>CATABOLISMO<|>Parenteral nutrition is designed to support the catabolic processes in patients who cannot eat normally.<|>6)\n##\n(\"relationship\"<|>AMINOÁCIDOS<|>NUTRICIÓN PARENTERAL<|>Amino acids are essential components of parenteral nutrition formulations, providing necessary nutrients for patients.<|>9)\n##\n(\"relationship\"<|>FIEBRE<|>NUTRICIÓN PARENTERAL<|>Fever can be a complication in patients receiving parenteral nutrition, indicating possible infection.<|>5)\n##\n(\"relationship\"<|>SEPSIS<|>NUTRICIÓN PARENTERAL<|>Sepsis is a serious risk for patients on parenteral nutrition due to potential infections from catheter use.<|>8)\n##\n(\"relationship\"<|>TROMBOSIS<|>NUTRICIÓN PARENTERAL<|>Thrombosis is a potential complication associated with the prolonged use of catheters in parenteral nutrition.<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ado con antibióticos en\n         D.  Todas las respuestas anteriores son correctas.                                                                                               función del resultado del antibiograma.\n                                                                                                                                                      C. Tratamiento con soluciones antisépticas como etanol o taurolidina.\n         COMENTARIO                                                                                                                                   D.  Todas las alternativas anteriores son correctas.\n         En la tabla 6 se muestran los requerimientos para la composición de la nutrición parenteral.                                                 COMENTARIO\n         Los pacientes con encefalopatía hepática presentan un aminograma plasmático con un\n         descenso de los aminoácidos de cadena ramificada (valina, isoleucina y leucina) aumento                                                      Los criterios de retirada de catéter venoso central en NP son:\n         de los aminoácidos aromáticos (fenilalanina, triptófano y tirosina) y de metionina y glutami-                                                •  Persistencia de fiebre o bacteriemia tras 48-72 horas de iniciado el tratamiento antibiótico.\n         na. El paso de aminoácidos aromáticos a través de la barrera hematoencefálica favorecería                                                    •  Existencia de metástasis séptica o tromboflebitis séptica.\n         el desarrollo de la encefalopatía. En casos de encefalopatía hepática grave, los pacientes se                                                •  Sepsis complicada con shock séptico, insuficiencia renal aguda, distrés respiratorio, etc.\n         podrían beneficiar de fórmulas ricas en aminoácidos ramificados y pobres en aromáticos.                                                      •  Infecciones causadas por hongos o microorganismos difícilmente tratados con antibióti-\n         Respecto al aporte lipídico, en los pacientes con insuficiencia hepática o renal graves, crí-                                                   cos (S. aureus, Pseudomonas spp.) o infecciones polimicrobianas.\n         ticos o NP a largo plazo no se deben emplear a una dosis superior a 1 g/kg/día y se han                                                      •  Infección del túnel.\n\n\n\n224                                                                                                                                                                                                                                                                                  225\n---\n                                                                                                                                                                                                                                             NUTRICIÓN                            4\n\n\n\n         Las soluciones de etanol y taurolidina se emplean de forma profiláctica como sellado del                                                      Respecto a las complicaciones relacionadas con el catéter, la prevención de trombosis ve-\n         catéter con el objetivo de disminuir la incidencia de infecciones asociadas a catéter, aunque                                                 nosa se realizará de forma individualizada en pacientes o situaciones de alto riesgo; asimis-\n         parece que los beneficios se obtienen solo en pacientes de alto riesgo. Además, el etanol                                                     mo, el sellado de catéter con etanol para la prevención de infecciones recurrentes puede\n         puede tener efectos adversos de daño a los polímeros del catéter y facilitar así la aparición                                                 dañar los polímeros del catéter y aumentar la aparición de trombosis.\n         de trombosis.                                                                                                                                 Referencias:\n         Referencias:                                                                                                                                  • Martínez Faedo C, Laborda González L, Virgili Casas N, Gómez Enterría P y grupo de trabajo NADYA-SENPE. Complicaciones\n         • Wanden-Berghe Lozano C, Cuerda Compés MC, Luengo Pérez LM. Nutrición artificial domiciliaria. Cap. 19. Tomo V. En: Gil Hernández              hepatobiliares asociadas a la Nutrición Parenteral Domiciliaria (NPD). Nutr Hosp. 2011;26(3):579-88.\n           A, Fontana Gallego L, Sánchez de Medina Contreras F, eds. Tratado de Nutrición. 3.ª ed. Madrid: Editorial Médica Panamericana;              • Wanden-Berghe Lozano C, Cuerda Compés MC, Luengo Pérez LM. Nutrición artificial domiciliaria. Cap. 19. Tomo V. En: Gil Hernández\n           2017. p. 311-25.                                                                                                                              A, Fontana Gallego L, Sánchez de Medina Contreras F, eds. Tratado de Nutrición. 3.ª ed. Madrid: Editorial Médica Panamericana;\n                                                                                                                                                         2017. p. 311-25.\n\n\n\n     32  Respecto al manejo de las complicaciones de la nutrición parenteral domiciliaria                                                    4.5 Nutrición en situaciones especiales\n         (NPD):\n         A. En algunos casos está recomendado el sellado del catéter con etanol al 70% para\n             prevenir infecciones recurrentes.                                                                                                  33     ¿Cuál de los siguientes aspectos no se contempla en el soporte nutricional\n         B. Se aconseja de forma habitual en el empleo de anticoagulantes orales como medio de                                                         del paciente quirúrgico?\n             prevención de las trombosis venosas asociadas al uso prolongado del catéter.                                                              A. Reiniciar la nutrición oral tras la cirugía tan pronto como sea posible.\n         C. Cuando existe enfermedad hepática asociada al fal\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>MARTÍNEZ FAEDO C<|>PERSON<|>Martínez Faedo C is an author referenced in the context of complications associated with home parenteral nutrition.)\n##\n(\"entity\"<|>LABORDA GONZÁLEZ L<|>PERSON<|>Laborda González L is an author referenced in the context of complications associated with home parenteral nutrition.)\n##\n(\"entity\"<|>VIRGILI CASAS N<|>PERSON<|>Virgili Casas N is an author referenced in the context of complications associated with home parenteral nutrition.)\n##\n(\"entity\"<|>GÓMEZ ENTERRÍA P<|>PERSON<|>Gómez Enterría P is an author referenced in the context of complications associated with home parenteral nutrition.)\n##\n(\"entity\"<|>NADYA-SENPE<|>ORGANIZATION<|>NADYA-SENPE is a working group involved in the study of hepatobiliary complications associated with home parenteral nutrition.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL DOMICILIARIA<|>EVENT<|>Home parenteral nutrition refers to the administration of nutrients directly into the bloodstream for patients at home.)\n##\n(\"entity\"<|>ETANOL<|>ORGANIZATION<|>Ethanol is used prophylactically to seal catheters to reduce the incidence of catheter-associated infections.)\n##\n(\"entity\"<|>TAUROLIDINA<|>ORGANIZATION<|>Taurolidine is used prophylactically to seal catheters to reduce the incidence of catheter-associated infections.)\n##\n(\"relationship\"<|>MARTÍNEZ FAEDO C<|>NADYA-SENPE<|>Martínez Faedo C is part of the working group NADYA-SENPE that studies complications related to home parenteral nutrition.<|>7)\n##\n(\"relationship\"<|>LABORDA GONZÁLEZ L<|>NADYA-SENPE<|>Laborda González L is part of the working group NADYA-SENPE that studies complications related to home parenteral nutrition.<|>7)\n##\n(\"relationship\"<|>VIRGILI CASAS N<|>NADYA-SENPE<|>Virgili Casas N is part of the working group NADYA-SENPE that studies complications related to home parenteral nutrition.<|>7)\n##\n(\"relationship\"<|>GÓMEZ ENTERRÍA P<|>NADYA-SENPE<|>Gómez Enterría P is part of the working group NADYA-SENPE that studies complications related to home parenteral nutrition.<|>7)\n##\n(\"relationship\"<|>ETANOL<|>NUTRICIÓN PARENTERAL DOMICILIARIA<|>Ethanol is used in home parenteral nutrition to prevent recurrent infections by sealing catheters.<|>8)\n##\n(\"relationship\"<|>TAUROLIDINA<|>NUTRICIÓN PARENTERAL DOMICILIARIA<|>Taurolidine is used in home parenteral nutrition to prevent recurrent infections by sealing catheters.<|>8)\n<|COMPLETE|>"}]}